Goldman Sachs Asset Management will acquire Dutch pharmaceuticals company Norgine, beating out Bain and Cinven in the final leg of an auction.
Goldman Sachs Asset Management will acquire Dutch pharmaceuticals company Norgine, beating out Bain and Cinven in the final leg of an auction.